COVID-19: NJ drugmaker Merck says new antiviral drugs show rapid virus reduction
Experimental antiviral drug molnupiravir, developed by New Jersey drugmaker Merck with Ridgeback Bio, shows a rapid reduction of the infectious virus in a study among participants with early COVID-…
